HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
MMSI
Merit Medical Systems, Inc.
MMSI's fundamentals are strong and it looks cheap: trading at 32x earnings, below its usual 49x. Analysts expect earnings growth.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
MMSI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
MMSI's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
MMSI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 19x | $86.69 | — |
| Current | 32x | $86.69 | — |
| Cheap | 42x | $112 | +29% |
| Fair | 49x | $132 | +52% |
| Expensive | 84x | $223 | +157% |
Historical ranges are pointers, not guarantees.
MMSI's PE is in its cheap range at 32x. If earnings grow as analysts expect, today's price would be 19x next year's earnings.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
MMSI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
MMSI has the edge over HIMS on the outlook, with more favorable earnings and profitability expectations.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
MMSI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.49 | +68% |
| Q3 2026 | $2.67 | +37% |
| Q2 2026 | $2.43 | +23% |
| Q1 2026 | $2.32 | +14% |
| Q4 2025 | $2.13 | +4.9% |
| Q3 2025 | $1.95 | -4.4% |
| Q2 2025 | $1.97 | -1.5% |
| Q1 2025 | $2.04 | +17% |
| Q4 2024 | $2.03 | +25% |
MMSI has the edge over HIMS on earnings quality, reporting a profit while its opponent remains loss making.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over MMSI on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS's operating margin was −7.4% last quarter, down 9.4 points from the same quarter a year ago.
MMSI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $416.2M | +8.4% |
| Q2 2026 | $418.8M | +9.5% |
| Q1 2026 | $381.9M | +7.5% |
| Q4 2025 | $393.9M | +11% |
| Q3 2025 | $384.2M | +13% |
| Q2 2025 | $382.5M | +13% |
| Q1 2025 | $355.4M | +9.8% |
| Q4 2024 | $355.2M | +9.4% |
MMSI's revenue has grown year over year every quarter since late 2020: $416M last quarter, up 8.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +3 points |
| Q2 2026 | 14% | +2.2 points |
| Q1 2026 | 12% | 0 points |
| Q4 2025 | 14% | +3.5 points |
| Q3 2025 | 11% | +0.1 points |
| Q2 2025 | 12% | -1.3 points |
| Q1 2025 | 12% | +0.5 points |
| Q4 2024 | 10% | -0.1 points |
MMSI has the edge over HIMS on profitability, with a higher operating margin.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over MMSI on cash flow, with more consistent year-over-year improvement.
MMSI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $52.9M | +0.7% |
| Q2 2026 | $51.9M | -25% |
| Q1 2026 | $24.7M | +26% |
| Q4 2025 | $74M | +13% |
| Q3 2025 | $52.5M | +38% |
| Q2 2025 | $69.6M | +20% |
| Q1 2025 | $19.5M | -20% |
| Q4 2024 | $65.3M | +18% |
MMSI's free cash flow has been positive every quarter for seven years: $204M over the past year, down 1.6% from the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over MMSI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
MMSI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +373K shares |
| 1 year | +0.8% | +460K shares |
| 3 years | +3.4% | +2M shares |
| 5 years | +4.9% | +2.8M shares |
| Available history | +7.4% | +4.1M shares |
MMSI has 60M diluted shares, up 0.8% from a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
MMSI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.9x | Very low |
| Q1 2026 | 0.8x | Very low |
| Q4 2025 | 0.9x | Very low |
| Q3 2025 | 1.2x | Healthy |
| Q2 2025 | 1.4x | Healthy |
| Q1 2025 | 1.2x | Healthy |
| Q4 2024 | 1.4x | Healthy |
MMSI's net debt is less than a year of its operating earnings (EBITDA), down from 1.2 years a year ago.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
MMSI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.9 | Neutral |
| Stochastic | 40.0 | Neutral |
MMSI's weekly RSI is 56 (neutral) and its Stochastic is 40 (neutral).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
MMSI PE vs Healthcare Sector
| Metric | MMSI | Sector median | Relative |
|---|---|---|---|
| PE | 32x | 26x | 26% above |
| PE % | 6 | 29 | 23 pts below |
MMSI is trading at 32x earnings, a 26% premium to the Healthcare sector's median of 26x.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
MMSI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $87.8 | 1.3% below |
| 20 week MA | $85.2 | 1.8% above |
| 50 week MA | $78.5 | 10% above |
| 100 week MA | $85.8 | 1.1% above |
| 200 week MA | $82.9 | 4.5% above |
MMSI has the edge over HIMS on trend strength, trading above more of its moving averages.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.
MMSI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.3 | $54.5 | +74% |
| 2021 | $54.5 | $63.7 | +17% |
| 2022 | $63.7 | $70.9 | +11% |
| 2023 | $70.9 | $76.0 | +7.2% |
| 2024 | $76.0 | $97.3 | +28% |
| 2025 | $97.3 | $87.4 | -10% |
| 2026 YTD | $87.4 | $86.7 | -0.8% |
MMSI has the edge over HIMS on returns for 2026, with the stronger performance.